Published in Scand J Gastroenterol on April 01, 1999
Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging. World J Gastroenterol (2000) 1.34
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut (2002) 1.14
Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J Gastroenterol (2003) 1.09
Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol Pathol (2003) 1.06
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Mol Pathol (2002) 1.04
Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology (2009) 1.02
Apoptotic signaling pathway activated by Helicobacter pylori infection and increase of apoptosis-inducing activity under serum-starved conditions. Infect Immun (2001) 1.00
Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun (2003) 0.98
H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol (2008) 0.94
Effect of Helicobacter pylori infection on expression of Bcl-2 family members in gastric adenocarcinoma. World J Gastroenterol (2004) 0.94
Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol (2012) 0.93
Bax translocation and mitochondrial fragmentation induced by Helicobacter pylori. Gut (2004) 0.91
Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients. Dig Dis Sci (2003) 0.91
Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease. World J Gastroenterol (2005) 0.81
Epithelial cell expression of BCL-2 family proteins predicts mechanisms that regulate Helicobacter pylori-induced pathology in the mouse stomach. Lab Invest (2008) 0.79
Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis. World J Gastroenterol (2015) 0.78
HOGG1 polymorphism in atrophic gastritis and gastric cancer after Helicobacter pylori eradication. World J Gastroenterol (2010) 0.76
Helicobacter pylori γ-glutamyl transpeptidase: a formidable virulence factor. World J Gastroenterol (2013) 0.75
Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure. World J Gastroenterol (2005) 0.75
Helicobacter pylori. Mol Pathol (2002) 0.75
Role of protease-activated receptor-2 on cell death and DNA fragmentation in Helicobacter pylori-infected gastric epithelial cells. J Transl Med (2010) 0.75
Gastric mucosa epithelial cell kinetics are differentiated by anatomic site and Helicobacter pylori infection. Dig Dis Sci (2005) 0.75
Differential expression of MYC in H. pylori-related intestinal and diffuse gastric tumors. Virchows Arch (2011) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology (1974) 2.87
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology (1999) 2.71
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis (2001) 2.42
In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology (1989) 2.34
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol Microbiol (1999) 2.06
Successful treatment of Bouveret's syndrome by endoscopic laserlithotripsy. Endoscopy (1999) 2.00
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology (1998) 1.92
Tele-endoscopy: influence of data compression, bandwidth and simulated impairments on the usability of real-time digital video endoscopy transmissions for medical diagnoses. Endoscopy (2002) 1.89
Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83
Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83
Benefits and risks of needle-knife papillotomy. Gastrointest Endosc (1997) 1.80
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (1982) 1.80
Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke (2001) 1.76
Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. Gastroenterology (1976) 1.74
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion (1987) 1.69
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut (1998) 1.67
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66
Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol (2011) 1.62
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology (1989) 1.60
An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology (2000) 1.60
Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60
Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis (2001) 1.59
Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol (2002) 1.55
Hepatitis C and liver fibrosis. Cell Death Differ (2003) 1.53
Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology (1981) 1.52
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. Gastroenterology (1974) 1.51
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology (1975) 1.49
Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer (2011) 1.46
Correlation of polypoid lesions in the distal colorectum and proximal colon in asymptomatic screening subjects. Eur J Gastroenterol Hepatol (1996) 1.45
[Auto-CPAP treatment in obstructive sleep apnea syndrome: a prospective randomized study during initiation of treatment]. Dtsch Med Wochenschr (1997) 1.43
Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut (2002) 1.43
Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J (2003) 1.41
Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2000) 1.40
Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology (1981) 1.40
[Decision to use complementary medicine: fact oriented or irrational?]. Dtsch Med Wochenschr (1996) 1.39
Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology (2001) 1.39
Disposable-sheath, flexible gastroscope system versus standard gastroscopes: a prospective, randomized trial. Gastrointest Endosc (1999) 1.38
Balanitis xerotica obliterans in monozygotic twins. Br J Urol (1997) 1.38
Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc (1999) 1.37
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man. Am J Dig Dis (1974) 1.32
Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol (2001) 1.32
Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol (2009) 1.31
Management of difficult common bile duct stones. Gastrointest Endosc Clin N Am (2003) 1.31
Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J (1998) 1.30
Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut (2002) 1.29
Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28
Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy. Am J Dig Dis (1968) 1.28
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc (1999) 1.28
Effect of medical and surgical vagotomy on gastric response to graded doses of pentagastrin and histamine. Gastroenterology (1968) 1.28
Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine (2000) 1.27
Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc (2001) 1.26
The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26
Distribution and release of epidermal growth factor in man. Gut (1989) 1.25
Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Gut (1987) 1.24
Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24
Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol Ther (2000) 1.23
Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium. Mol Microbiol (2000) 1.23
Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol (1975) 1.23
Abdominal actinomycosis: complication of endoscopic stenting in chronic pancreatitis? Endoscopy (2001) 1.23
Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. Gut (1979) 1.22
Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest (1976) 1.22
Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis (1997) 1.21
Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21
Gastric cytoprotection. Scand J Gastroenterol (1985) 1.21
Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut (1981) 1.21
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
Late pulmonary metastasis in uterine PEComa. J Clin Pathol (2003) 1.20
Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. J Physiol (1976) 1.19
Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept (2004) 1.18
Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol (1999) 1.18
Comparison of amino acids bathing the oxyntic gland area in the stimulation of gastric secretion. Gastroenterology (1976) 1.18
Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Endoscopy (1999) 1.18